Caren van Roekel

288 Chapter 10 94. Rose SC, Narsinh KH, Newton IG. Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series. J Vasc Interv Radiol. 2017;28(1):103-10. Epub 2016/11/15. 95. Pasciak AS, McElmurray JH, Bourgeois AC, Heidel RE, Bradley YC. The impact of an antireflux catheter on target volume particulate distribution in liver-directed embolotherapy: a pilot study. J Vasc Interv Radiol. 2015;26(5):660-9. Epub 2015/03/25. 96. Titano JJ, Fischman AM, Cherian A, Tully M, Stein LL, Jacobs L, et al. End-hole Versus Microvalve Infusion Catheters in Patients Undergoing Drug-Eluting Microspheres-TACE for Solitar y Hepatocellular Carcinoma Tumors: A Retrospective Analysis. Cardiovasc Interv Radiol. 2019;42(4):560-8. Epub 2019/01/13. 97. van den Hoven AF, Smits ML, Rosenbaum CE, Verkooijen HM, van den Bosch MA, Lam MG. The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review. PloS One. 2014;9(1):e86394. Epub 2014/01/28. 98. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-47. Epub 2008/12/23. 99. Hyun O, J. , Lodge MA, Wahl RL. Practical PERCIST: A simplified guide to PET response criteria in solid tumors. RadioGraphics. 2016;280(2):576-84. 100. Heinemann V, Stintzing S, Modest DP, Giessen-Jung C, Michl M, Mansmann UR. Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC). Eur J Cancer. 2015;51(14):1927-36. Epub 2015/07/21. 101. Sager S, Akgun E, Uslu-Besli L, Asa S, Akovali B, Sahin O, et al. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma. Nucl Med Commun. 2019;40(5):461-8. Epub 2019/03/22. 102. Bastiaannet R, Lodge MA , de Jong H, Lam M. The Unique Role of Fluorodeox yglucose-PE T in Radioemboliz ation. PE T Clin. 2019;14(4):447-57. Epub 2019/09/02. 103. Tsuji A, Sunakawa Y, Ichikawa W, Nakamura M, Kochi M, Denda T, et al. Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05). Target Oncol. 2016;11(6):799- 806. Epub 2016/06/17.